SynthesisJournal of extracellular vesicles2026
Diagnostic and Therapeutic Roles of Extracellular Vesicles in Chronic Kidney Disease: A Systematic Review.
Synthesis in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Roles of Biomarkers in Chronic Kidney Disease and Related Conditions.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Extracellular vesicles (EVs) are increasingly investigated across a wide range of diseases as potential biomarkers and therapeutic tools. To date, EVs have been isolated from diverse sources, including urine, blood, saliva, tissue, and cell cultures, with research focusing primarily on their protein and RNA cargo. Owing to their non-invasive accessibility, selective cargo loading, and molecular richness, biological fluid-derived EVs have been proposed as promising candidates for biomarker discovery. In addition, several studies have explored EVs for therapeutic purposes, either by direct administration to diseased cells or organisms, by engineering them to enhance their efficacy, or by targeting them to modulate pathological processes. In this systematic review, we synthesize current evidence on the diagnostic and therapeutic roles of EVs in CKD and related conditions, integrating findings across different EV sources, cargos, and disease models, and providing an integrated perspective on the role of EVs in chronic kidney disease-related research. By comparing molecular findings from diagnostic and therapeutic studies, we also identify key overlapping pathways and biological processes that may represent relevant mechanistic frameworks. Recognizing these convergent pathways can help unify data and guide future research toward mechanism-driven, and clinically translatable EV applications in nephrology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.